Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients
Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this trial is to determine if the treatment with rosuvastatin 10 and
20mg/day during 8 weeks in hypertriglyceridemic patients will reduce their triglyceride
levels.